Master data| INID | Criterion | Field | Content |
|---|
| Type of IP right | SART | Patent |
| Status | ST | Pending/in force |
| 21 | DE file number | DAKZ | 60 2015 088 211.3 |
| 96 | EP file number | EAKZ | 21 16 0203.2 |
| 97 | EP publication number | EPN | 3888674 |
| 54 | Designation/title | TI | BEHANDLUNG VON KREBS MITTELS CHIMÄREM ANTI-CD19-ANTIGENREZEPTOR |
| 51 | IPC main class | ICM
(ICMV) | A61K 39/00 (2006.01) |
| 51 | IPC secondary class(es) | ICS
(ICSV) | A61K 31/436 (2006.01), A61P 35/02 (2006.01), A61K 35/17 (2025.01) |
| 22 | DE application date | DAT | Apr 7, 2015 |
| 96 | EP application date | EAT | Apr 7, 2015 |
| 43 | Date of first publication | OT | Oct 6, 2021 |
| Date of publication of grant | PET | Apr 3, 2024 |
| 71/73 | Applicant/owner | INH | Novartis AG, Basel, CH; The Trustees of The University of Pennsylvania, Philadelphia, PA, US |
| 72 | Inventor | IN | BYRD, John, Columbus, OH 43212, US; DUBOVSKY, Jason, Columbus, OH 43235, US; FRAIETTA, Joseph, Cherry Hill, NJ 08002, US; GILL, Saar, Philadelphia, PA 19106, US; GLASS, David, Cambridge, MA 02139, US; JOHNSON, Amy, Dublin, OH 43016, US; JUNE, Carl H., Merion Station, PA 19066, US; KENDERIAN, Saad, Philadelphia, PA 19146, US; MANNICK, Joan, Cambridge, MA 02139, US; MAUS, Marcela, Bryn Mawr, PA 19010, US; MURPHY, Leon, Cambridge, MA 02139, US; MUTHUSAMY, Natarajan, Galloway, OH 43119, US; PORTER, David L., Springfield, PA 19064, US; RUELLA, Marco, Philadelphia, PA 19143, US; SELLERS, William Raj, Cambridge, MA 02139, US; WASIK, Mariusz, Ardmore, PA 19003, US; BROGDON, Jennifer, Cambridge, MA 02139, US |
| 74 | Representative | VTR | Mathys & Squire Europe Patentanwälte Partnerschaft mbB, 80333 München, DE |
| Address for service | | Mathys & Squire Europe Patentanwälte Partnerschaft mbB, 80333 München, DE |
33
31
32
| Foreign priority | PRC
PRNA
PRDA
| US
201462007309 P
Jun 3, 2014
|
33
31
32
| Foreign priority | PRC
PRNA
PRDA
| US
201462036493 P
Aug 12, 2014
|
33
31
32
| Foreign priority | PRC
PRNA
PRDA
| US
201462076238 P
Nov 6, 2014
|
33
31
32
| Foreign priority | PRC
PRNA
PRDA
| US
201462097278 P
Dec 29, 2014
|
33
31
32
| Foreign priority | PRC
PRNA
PRDA
| US
201461976396 P
Apr 7, 2014
|
33
31
32
| Foreign priority | PRC
PRNA
PRDA
| US
201462087888 P
Dec 5, 2014
|
| Due date | FT
FG | Apr 30, 2026
Annual fee for the 12th year
Patent fees |
| Patent division in charge | | 44 |
| 97 | EP language of publication | ELANG | EN - Englisch |
| 84 | Designated EP contracting states | EDS | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000003888674A1
Searchable text:
EP000003888674A1
Original document:
EP000003888674B1
Searchable text:
EP000003888674B1 |
| 43 | Date of first publication | EVT | Oct 6, 2021 |
| Date of the first transfer into DPMAregister | EREGT | Oct 6, 2021 |
| Date of the (most recent) update in DPMAregister | REGT | Apr 24, 2025
(Show all update days)(Hide all update days)- Apr 24, 2025
- Procedures: Procedure relating to EP application, EPO publication of mention of grant , 03.04.2024: new
- Procedures: Procedure relating to EP application, EPO publication of mention of grant , 03.04.2024: deleted
- Mar 26, 2025
- Feb 20, 2025
- St.36: changed (technical change)
- Feb 13, 2025
- Procedures: Opposition procedure, Opposition filed, 03.01.2025: changed
- Jan 23, 2025
- IPC secondary class(es): changed
- Procedures: Opposition procedure, Opposition filed, 03.01.2025: new
- Nov 14, 2024
- St.36: changed (technical change)
- Oct 31, 2024
- St.36: changed (technical change)
- Jun 28, 2024; May 18, 2024; May 8, 2024; Apr 11, 2024; Mar 15, 2024; Mar 14, 2024
- Historical data not available for this/these date(s)
- Oct 6, 2021
- Date of the first transfer into DPMAregister
|
